Lunai Bioworks Announces Voluntary Delisting from Nasdaq and Deregistration
Lunai Bioworks Inc. (Nasdaq: LNAI) announced on October 21, 2026, that it received a delisting notice from Nasdaq for failing to meet continued listing requirements—including minimum bid price and stockholders’ equity. The company intends to voluntarily delist and file Form 15 to deregister with the SEC.
51CFO view：Voluntary delisting demands CFOs master ASC 718/480 accounting adjustments, Form 15 preparation, and buy-side due diligence packaging. For China-linked issuers, this highlights the need for CFOs fluent in both U.S. GAAP transitions and SEC deregistration mechanics—not just IPO execution.
Lunai Bioworks Inc. (Nasdaq: LNAI) announced on October 21, 2026, that it received a delisting notice from Nasdaq for failing to meet continued listing requirements—including minimum bid price and stockholders’ equity. The company intends to voluntarily delist and file Form 15 to deregister with the SEC.
Source：PR Newswire 金融
Why this matters to your CFO search
Where this touches your finance hire
Every listing event changes what you need from a CFO. Start from the step you are actually at.
What kind of CFO does a US IPO need?
S-1 / F-1 filing, US GAAP conversion, roadshow — the hard requirements.
Read →
Who owns SEC reporting and US GAAP?
Signature responsibility for 10-K / 10-Q / 8-K / 20-F, and common comments.
Read →
Who runs finance through a SPAC merger?
De-SPAC files F-1 / 424(b); merger audit and disclosure cadence differ.
Read →